목차
1.약물요법의 원칙
2.비만치료제의 종류
3. 향후 개발 가능한 비만증치료제
4. 결론
2.비만치료제의 종류
3. 향후 개발 가능한 비만증치료제
4. 결론
본문내용
ines on the identification, evaluation and treatment of overweight and obesity in adults., pp.56-71, 1998
3. Davidson MH, Haptman J, DeGirolamo M et al.: Weight control and risk factor reduction in obese subjects treated for 2 years with Orlistat. JAMA 281:235-242, 1999
4. National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 276:1907-195, 1996
5. Lean M: Sibutramine. Int J Obesity 21(Suppl 1):S30-S36, 1997
6. Carruba M, Tomello C, Briscini L, Nisoli E: Advances in pharmacotherapy for obesity. Int J Obes 22:S13-S16, 1998
3. Davidson MH, Haptman J, DeGirolamo M et al.: Weight control and risk factor reduction in obese subjects treated for 2 years with Orlistat. JAMA 281:235-242, 1999
4. National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 276:1907-195, 1996
5. Lean M: Sibutramine. Int J Obesity 21(Suppl 1):S30-S36, 1997
6. Carruba M, Tomello C, Briscini L, Nisoli E: Advances in pharmacotherapy for obesity. Int J Obes 22:S13-S16, 1998
소개글